Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

VesiBeta 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Mirabegron (25mg)

Overview VesiBeta 25 Tablet ER

VesiBeta 25 Extended-Release tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication promotes bladder muscle relaxation, enhancing urinary storage capacity. Always adhere to your physician's prescribed dosage and regimen. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects promptly to your doctor. Prior to commencing treatment, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding. Individuals with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.

Primary Ingredients of VesiBeta 25 Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of VesiBeta 25 Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of VesiBeta 25 Tablet ER:

Administer VesiBeta 25 Tablet ER precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.

Common Side effects of VesiBeta 25 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use VesiBeta 25 Tablet ER:

Administer VesiBeta 25 Tablet ER precisely as prescribed by your physician, adhering to the specified dosage and treatment period. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.

How VesiBeta 25 Tablet ER works:

VesiBeta 25 Extended-Release tablets utilize a beta-3 adrenergic agonist mechanism. This medication's action involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and, consequently, a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Using VesiBeta 25 Tablet ER with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release VesiBeta 25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release VesiBeta 25mg tablets are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by VesiBeta 25 ER tablets.

KidneyKidneyCAUTION

Extended-release VesiBeta 25 tablets require careful administration in individuals with advanced renal impairment. Dosage modification for VesiBeta 25 ER may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use VesiBeta 25 Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician. VesiBeta 25 Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take VesiBeta 25 Tablet ER :

Should you forget a dose of VesiBeta 25 Tablet ER, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About VesiBeta 25 Tablet ER

LabelValue
Chemical Classification Anilide-based compound
Developing Habits No.
Treatment Category Urological Care
Actions β3-Adrenergic receptor agonist (for bladder)

FAQs on VesiBeta 25 Tablet ER

Optimal benefits from VesiBeta 25 Tablet ER may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4–8 weeks, depending on individual response.
Continue taking VesiBeta 25 Tablet ER, even if your symptoms improve. This medication doesn't cure overactive bladder; it manages urgency, frequent urination, and incontinence. Stopping treatment could bring back your symptoms.
VesiBeta 25 Tablet ER shouldn't interfere with your sleep. Consult your doctor if you experience any sleep-related issues.
VesiBeta 25 Tablet ER should not be given to children under 18, as its safety and efficacy in this age group haven't been established.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not curing it. Intermittent use prevents your bladder from adapting and will lead to recurring symptoms.
VesiBeta 25 Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and report any kidney-related symptoms to their doctor.
VesiBeta 25 Tablet ER should be used cautiously if you have high blood pressure, as it may raise blood pressure in some individuals. Regular blood pressure monitoring is essential. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of symptoms. A VesiBeta 25 Tablet ER overdose can raise heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
VesiBeta 25 Tablet ER
199
MRP 242
17% off